CytoDyn Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price

CytoDyn Inc. (CYDY) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $1.00 per share for the 6-month period ending 2013-11-30, per its 10-Q filed 2014-01-13.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2014-07-10

CytoDyn Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2012-08-31 was $0.25.
CytoDyn Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2013 was $0.26, a 58.06% decline from fiscal 2012.
CytoDyn Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2012 was $0.62.

Period end	Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month	Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month	Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month	Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month
2013-11-30		$1.00 10-Q · filed 2014-01-13
2013-05-31				$0.26 10-K · filed 2014-07-10
2013-02-28			$0.25 10-Q · filed 2013-04-12
2012-11-30		$0.25 10-Q · filed 2013-01-14
2012-08-31	$0.25 10-Q/A · filed 2012-11-08
2012-05-31				$0.62 10-K · filed 2013-08-29